Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials

Mannucci Edoardo; Monami Matteo

首页> 外文期刊>Advances in therapy. >Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials

【24h】

Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials

机译：2型糖尿病患者的基于胰素的疗法的心血管安全性：对综合分析和随机对照试验的系统审查

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Regulatory requirements mandate that new drugs for treatment of patients with type 2 diabetes mellitus (T2DM), such as dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, are evaluated to show that they do not increase cardiovascular (CV) risk.

机译：监管要求授权用于治疗2型糖尿病患者（T2DM）的新药，例如二肽基肽酶-4（DPP-4）抑制剂和胰高血糖素样肽-1（GLP-1）受体激动剂进行评估它们不会增加心血管（CV）风险。

著录项

来源
《Advances in therapy.》 |2017年第1期|共40页
作者
Mannucci Edoardo; Monami Matteo;
展开▼
作者单位

Careggi Teaching Hosp Diabetol Florence Italy;

Careggi Teaching Hosp Div Geriatr Cardiol &

Med Florence Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
Cardiovascular risk; Dipeptidyl peptidase-4 inhibitor; Glucagon-like peptide-1 receptor agonist; MACE; Type 2 diabetes mellitus;

机译：心血管风险;二肽肽肽酶-4抑制剂;胰高血糖素样肽-1受体激动剂;坐垫;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials [J] . Mannucci Edoardo, Monami Matteo Advances in therapy. . 2017,第1期

机译：2型糖尿病患者的基于胰素的疗法的心血管安全性：对综合分析和随机对照试验的系统审查
2. Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials [J] . Pravesh K Bundhun, Tao Qin, Meng-Hua Chen BMC Cardiovascular Disorders . 2015,第1期

机译：比较三联抗血小板治疗和二联抗血小板治疗在2型糖尿病患者冠状动脉支架植入术后的有效性和安全性：随机对照试验的系统评价和荟萃分析
3. Interventions to improve patients’ compliance with therapies aimed at lowering glycated hemoglobin (HbA1c) in type 1 diabetes: systematic review and meta-analyses of randomized controlled clinical trials of psychological, telecare, and educational interventions [J] . Luciana Ver?oza Viana, Marilia Brito Gomes, Lenita Zajdenverg, Trials . 2016,第1期

机译：改善患者对1型糖尿病患者糖尿病血红蛋白（HBA1c）的疗法遵守疗法的干预：系统审查和心理，远程和教育干预措施随机对照临床试验的荟萃分析
4. Stroke unit of integrative medicine for post stroke comorbid anxiety and depression: A systematic review and meta-analysis of 25 randomized controlled trials [C] . Lingfeng Zeng, Changrong Meng, Zhaohui Liang, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：中风后合并焦虑和抑郁的中西医结合卒中科：25项随机对照试验的系统评价和荟萃分析
5. An investigation on the determinants of the effectiveness of anti-hypertensive drugs for primary prevention of cardiovascular disease: A systematic review of randomized controlled trials [D] . Jiang, Yu 2007

机译：抗高血压药物初步预防心血管疾病有效性决定因素的调查 - 随机对照试验的系统综述
6. Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials [O] . Edoardo Mannucci, Matteo Monami -1

机译：2型糖尿病中以肠泌素为基础的疗法的心血管安全性：综合分析和随机对照试验的系统评价
7. Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials [O] . Edoardo Mannucci, Matteo Monami 2016

机译：2型糖尿病中以肠泌素为基础的疗法的心血管安全性：综合分析和随机对照试验的系统评价

Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials

摘要

著录项

相似文献

相关主题

期刊订阅